The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Cancer modeling meets human organoid technology
Open accessAbstract
Organoids are microscopic self-organizing, three-dimensional structures that are grown from stem cells in vitro. They recapitulate many structural and functional aspects of their in vivo counterpart organs. This versatile technology has led to the development of many novel human cancer models. It is now possible to create indefinitely expanding organoids starting from tumor tissue of individuals suffering from a range of carcinomas. Alternatively, CRISPR-based gene modification allows the engineering of organoid models of cancer through the introduction of any combination of cancer gene alterations to normal organoids. When combined with immune cells and fibroblasts, tumor organoids become models for the cancer microenvironment enabling immune-oncology applications. Emerging evidence indicates that organoids can be used to accurately predict drug responses in a personalized treatment setting. Here, we review the current state and future prospects of the rapidly evolving tumor organoid field.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“dynamic drug treatment was more effective than constant‐dose administration methods.”
From 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip (2023) · cites this paper as [105]
In the citing paper
“Using this system, the authors observed that significant differences in the response of individual PDOs to specific drug treatments and dynamic drug treatments could be more effective than constant‐dose therapy in vitro, indicating that this platform holds great potential to make clinical decisions for personalized therapy.”
From 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip (2023) · cites this paper as [105]
In the citing paper
“Using this system, the authors observed that significant differences in the response of individual PDOs to specific drug treatments and dynamic drug treatments could be more effective than constant‐dose therapy in vitro, indicating that this platform holds great potential to make clinical decisions for personalized therapy.”
From 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip (2023) · cites this paper as [105]
In the citing paper
“APCmin/+ mice can develop intestinal tumors around 10 weeks-old26”
From A PROTAC peptide induces durable β-catenin degradation and suppresses Wnt-dependent intestinal cancer (2020) · cites this paper as [26]
In the citing paper
“Wnt/β-catenin signaling is essential to maintain intestinal organoid growth26,27”
From A PROTAC peptide induces durable β-catenin degradation and suppresses Wnt-dependent intestinal cancer (2020) · cites this paper as [26]
In the citing paper
“The patient-derived tumor organoids, which recapitulate the complexity and heterogeneity of tumors, have been shown to be an ideal model for drug screening and precision medicine26.”
From A PROTAC peptide induces durable β-catenin degradation and suppresses Wnt-dependent intestinal cancer (2020) · cites this paper as [26]
In the citing paper
“These tumoroid biobanks can then be used as in vitro models of tumorigenesis and offer a significant advantage over conventional 2D cell culture technology5,6.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [6]
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., van Es, J. H., Abo, A., Kujala, P., Peters, P. J., et al. (2009) · Nature · doi:10.1038/nature07935 · Cited by 7,204
Self-citationCerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372
Sato, T., Stange, D. E., Ferrante, M., Vries, R. G. J., van Es, J. H., van den Brink, S., van Houdt, W. J., Pronk, A., van Gorp, J., Siersema, P. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.050 · Cited by 3,753
Self-citationDistinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162024 · Cited by 2,590
Self-citationProspective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
van de Wetering, M., Francies, H. E., Francis, J. M., Bounova, G., Iorio, F., Pronk, A., van Houdt, W., van Gorp, J., Taylor-Weiner, A., Kester, L., et al. (2015) · Cell · doi:10.1016/j.cell.2015.03.053 · Cited by 2,408
Self-citationOrganoid models of human and mouse ductal pancreatic cancer
Boj, S. F., Hwang, C.-I., Baker, L. A., Chio, I. I. C., Engle, D. D., Corbo, V., Jager, M., Ponz-Sarvise, M., Tiriac, H., Spector, M. S., et al. (2015) · Cell · doi:10.1016/j.cell.2014.12.021 · Cited by 2,150
Self-citationPatient-derived organoids model treatment response of metastatic gastrointestinal cancers
Vlachogiannis, G., Hedayat, S., Vatsiou, A., Jamin, Y., Fernández-Mateos, J., Khan, K., Lampis, A., Eason, K., Huntingford, I., Burke, R., et al. (2018) · Science · doi:10.1126/science.aao2774 · Cited by 2,096
A living biobank of breast cancer organoids captures disease heterogeneity
Sachs, N., de Ligt, J., Kopper, O., Gogola, E., Bounova, G., Weeber, F., Balgobind, A. V., Wind, K., Gracanin, A., Begthel, H., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.010 · Cited by 1,973
Self-citationBasal cells as stem cells of the mouse trachea and human airway epithelium
Rock, J. R., Onaitis, M. W., Rawlins, E. L., Lu, Y., Clark, C. P., Xue, Y., Randell, S. H., & Hogan, B. L. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906850106 · Cited by 1,591
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 938
Small ring has big potential: insights into extrachromosomal DNA in cancer
Wang, Y., Huang, R., Zheng, G., & Shen, J. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01936-6 · Cited by 17
Mauri, G., Durinikova, E., Amatu, A., Tosi, F., Cassingena, A., Rizzetto, F., Buzo, K., Arcella, P., Aquilano, M. C., Bonoldi, E., et al. (2021) · JCO Precision Oncology · doi:10.1200/po.21.00143 · Cited by 19
Xu, S., Fan, R., Wang, L., He, W., Ge, H., Chen, H., Xu, W., Zhang, J., Xu, W., Feng, Y., et al. (2021) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2021.2001805 · Cited by 16
Marinucci, M., Ercan, C., Taha‐Mehlitz, S., Fourie, L., Panebianco, F., Bianco, G., Gallon, J., Staubli, S. M., Soysal, S. D., Zettl, A., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.781833 · Cited by 17
Human fibroblasts facilitate the generation of iPSCs-derived mammary-like organoids
Dai, X., Wang, X., Yang, C., Huang, M., Zhou, Z., Qu, Y., Cui, X., Liu, R., & Chen, C. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03023-7 · Cited by 16
Kim, S., Park, J. Y., Lee, H. W., Bae, S. U., Kim, K. E., Byun, S. J., & Seo, I. (2023) · Scientific Reports · doi:10.1038/s41598-023-39488-6 · Cited by 16
Savary, C., Luciana, L., Huchedé, P., Tourbez, A., Coquet, C., Broustal, M., Gonzalez, A. L., Deligne, C., Diot, T., Naret, O., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101339 · Cited by 23
Prada, M. L., Espinet, E., Mijošek, V., Schwartz, U., Lutsik, P., Tamas, R., Richter, M., Behrendt, A., Pohl, S. T., Benz, N. P., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.140443 · Cited by 13
Pharmacological targeting of Sam68 functions in colorectal cancer stem cells
Masibag, A. N., Bergin, C. J., Haebe, J. R., Zouggar, A., Shah, M. S., Sandouka, T., da Silva, A. M., Desrochers, F. M., Fournier-Morin, A., & Benoit, Y. D. (2021) · iScience · doi:10.1016/j.isci.2021.103442 · Cited by 15
RETRACTED ARTICLE: Elucidation of CRISPR-Cas9 application in novel cellular immunotherapy
Quazi, S. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07147-0 · Cited by 22
RetractedColorectal Cancer Modeling with Organoids: Discriminating between Oncogenic RAS and BRAF Variants
Post, J. B., Roodhart, J. M. L., & Snippert, H. J. G. (2020) · Trends in cancer · doi:10.1016/j.trecan.2019.12.005 · Cited by 16
An organoids biobank for recapitulating tumor heterogeneity and personalized medicine
Yang, H., Zhang, N., & Liu, Y. (2020) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2020.03.12 · Cited by 17
Lee, M. G., Lee, B. R., Lee, P., Choi, S., Kim, J., Oh, M.-H., & Yoo, J. G. (2024) · Scientific Reports · doi:10.1038/s41598-024-82928-0 · Cited by 14
Li, S., Liu, C., & Weng, L. (2025) · Cancer Medicine · doi:10.1002/cam4.70620 · Cited by 15
Ma, H., Li, X., Li, J., Bu, J., Li, X., Zhang, J., Yu, S., Nie, G., Wang, H., & Feng, H. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123546 · Cited by 16
Noormohamadi, H., Samarkhazan, H. S., Kargar, M., Maroufi, F., Servatian, N., & Davami, F. (2025) · Discover Oncology · doi:10.1007/s12672-025-03383-5 · Cited by 17
Wang, Y., Zhang, L., Wang, L. Z., Cao, Y., Huang, L., Sethi, G., Chen, X., Wang, L., & Goh, B. C. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02429-0 · Cited by 19
Progress and perspective of organoid technology in cancer-related translational medicine
Lin, Y., Jiang, L., He, Q., Yuan, M., & Cao, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112869 · Cited by 18
Integrated platform for culture, observation, and parallelized electroporation of spheroids
Bregigeon, P., Rivière, C., Franqueville, L., Vollaire, C., Marchalot, J., & Frénéa‐Robin, M. (2022) · Lab on a Chip · doi:10.1039/d2lc00074a · Cited by 18
Zhao, Y. Q., Jin, H. R., Kim, D.-H., Jung, S. H., Liu, S., Wan, J., Lo, H., Fu, X. Q., Wang, Q., Hao, C., et al. (2023) · Molecular Carcinogenesis · doi:10.1002/mc.23560 · Cited by 15
In Vitro and In Vivo Drug-Response Profiling Using Patient-Derived High-Grade Glioma
Rajan, R. G., Fernández-Vega, V., Sperry, J., Nakashima, J. K., Do, L. H., Andrews, W., Boca, S. M., Islam, R., Chowdhary, S. A., Seldin, J., et al. (2023) · Cancers · doi:10.3390/cancers15133289 · Cited by 15
Deep Learning Model for Predicting Airway Organoid Differentiation
Lim, M. H., Shin, S., Park, K., Park, J., Kim, S. W., Basurrah, M. A., Lee, S., & Kim, D. H. (2023) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-023-00563-8 · Cited by 15
Decoding the obesity–cancer connection: lessons from preclinical models of pancreatic adenocarcinoma
Ruiz, C. F., Garcia, C. C., Jacox, J. B., Lawres, L., & Muzumdar, M. D. (2023) · Life Science Alliance · doi:10.26508/lsa.202302228 · Cited by 17
Huffman, B. M., Feng, H., Parmar, K., Wang, J., Kapner, K. S., Kochupurakkal, B. S., Martignetti, D. B., Sadatrezaei, G., Abrams, T. A., Biller, L. H., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-2005 · Cited by 15
Chen, D., Li, G., Luo, L., Liu, K., Chu, X., Liu, K., Lai, T., Liao, Y., Lin, X., & Chen, J. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156155 · Cited by 15
Busslinger, G. A., Lissendorp, F., Franken, I. A., van Hillegersberg, R., Ruurda, J. P. H., Clevers, H. C., & de Maat, M. F. G. (2020) · Open Biology · doi:10.1098/rsob.190274 · Cited by 15
Self-citationControlled Apoptosis of Stromal Cells to Engineer Human Microlivers
Chen, A. X., Chhabra, A., Song, H. G., Fleming, H. E., Chen, C. S., & Bhatia, S. N. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910442 · Cited by 15
Chang, T., Lu, C., Hsieh, Y., Wei, K., Chen, W., Tung, S.-Y., Wu, C., Chan, M. W. Y., & Chiang, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165901 · Cited by 15
Ex Vivo Analysis of Primary Tumor Specimens for Evaluation of Cancer Therapeutics
Tognon, C. E., Sears, R. C., Mills, G. B., Gray, J. W., & Tyner, J. W. (2020) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-043020-125955 · Cited by 15
Domenici, G., Eduardo, R., Castillo‐Ecija, H., Orive, G., Carcaboso, A. M., & Brito, C. (2021) · Cancers · doi:10.3390/cancers13040879 · Cited by 15
Engineering stromal heterogeneity in cancer
Tang, L. J. W., Zaseela, A., Toh, C. C. M., Adine, C., Aydar, A. O., Iyer, N. G., & Fong, E. L. S. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.027 · Cited by 15
Lee, H., Im, J. S., Choi, D. B., & Woo, D. (2021) · Organoid · doi:10.51335/organoid.2021.1.e11 · Cited by 17
Simão, D. F., Gomes, C. M., Alves, P. M., & Brito, C. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107883 · Cited by 15
Generation of prostate cancer assembloids modeling the patient-specific tumor microenvironment
Lee, J.-H., Kim, Y., Lee, C. M., Jeon, S. S., Seo, H. K., Lee, J. W., Choi, J., Kang, M., Kim, E., & Shin, K. (2025) · PLoS Genetics · doi:10.1371/journal.pgen.1011652 · Cited by 14
Huang, T. H., Huang, W. T., & Bian, Q. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114222 · Cited by 14
Zhao, H., Cheng, Y., Li, J., Zhou, J., Yang, H., Feng, Y., Yu, F., Khutsishvili, D., Wang, Z., Jiang, S., et al. (2022) · Fundamental Research · doi:10.1016/j.fmre.2022.05.018 · Cited by 15
Camacho-Gómez, D., Sorzabal-Bellido, I., Ortíz-de-Solórzano, C., García-Aznar, J., & Gómez-Benito, M. (2023) · iScience · doi:10.1016/j.isci.2023.107164 · Cited by 14
Lung cancer organoids: models for preclinical research and precision medicine
Liu, Y., Zhou, Y., & Chen, P. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1293441 · Cited by 14
Multi-omic dataset of patient-derived tumor organoids of neuroendocrine neoplasms
Alcala, N., Voegele, C., Mangiante, L., Sexton‐Oates, A., Clevers, H. C., Fernandez‐Cuesta, L., Dayton, T. L., & Foll, M. (2024) · GigaScience · doi:10.1093/gigascience/giae008 · Cited by 13
Self-citationImpacts of tissue context on extracellular vesicles‐mediated cancer–host cell communications
Nishida‐Aoki, N., & Ochiya, T. (2024) · Cancer Science · doi:10.1111/cas.16161 · Cited by 13
Zhang, Y., Liu, M., Xie, N., Wang, Z., Yu, C., Li, J., & Zhou, X. (2024) · hLife · doi:10.1016/j.hlife.2024.05.002 · Cited by 17
Advances in breast cancer research using CRISPR/Cas9 system
Eskandari, F., Aali, M., Hadisadegh, S. N., & Azadeh, M. (2024) · Nano Select · doi:10.1002/nano.202400015 · Cited by 18
Organoids in cancer therapies: a comprehensive review
Xin-Yi, J., Yan-Ran, W., Pin-Ru, D., Shi-Yi, Q., & Jiang, H. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1607488 · Cited by 17
Tumor Shrinkage by Metyrapone in Cushing Disease Exhibiting Glucocorticoid-Induced Positive Feedback
Tsujimoto, Y., Shichi, H., Fukuoka, H., Yamamoto, M., Sato, I., Imanishi, T., Nakamura, T., Inoshita, N., Ishida, A., Yamada, S., et al. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab055 · Cited by 14
Harnessing pluripotent stem cells as models to decipher human evolution
Dannemann, M., & Romero, I. G. (2021) · FEBS Journal · doi:10.1111/febs.15885 · Cited by 14
Ma, S., Zhao, H., & Galan, E. A. (2021) · Advanced Biology · doi:10.1002/adbi.202100535 · Cited by 14
Predicting flows through microfluidic circuits with fluid walls
Deroy, C., Stovall‐Kurtz, N., Nebuloni, F., Soitu, C., Cook, P. R., & Walsh, E. J. (2021) · Microsystems & Nanoengineering · doi:10.1038/s41378-021-00322-6 · Cited by 14
GPR87 Promotes Metastasis through the AKT-eNOS-NO Axis in Lung Adenocarcinoma
Ahn, H.-M., Choi, E.-Y., & Kim, Y. (2021) · Cancers · doi:10.3390/cancers14010019 · Cited by 14
Optimization of endometrial cancer organoids establishment by cancer-associated fibroblasts
Wu, Y.-L., Li, J., Sulaiman, Z., Liu, Q., Wang, C., Liu, S., Gao, Z., & Cheng, Z. (2022) · Neoplasma · doi:10.4149/neo_2022_211110n1597 · Cited by 13
Modeling epithelial-mesenchymal transition in patient-derived breast cancer organoids
Bar-Hai, N., Ben-Yishay, R., Arbili-Yarhi, S., Herman, N., Noy, V., Menes, T. S., Mansour, A., Awwad, F., Balint‐Lahat, N., Goldinger, G., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1470379 · Cited by 13
Hadefi, A., Leprovots, M., Thulliez, M., Bastin, O., Lefort, A., Libert, F., Nonclercq, A., Delchambre, A., Reniers, F., Deviere, J. M., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-00835-7 · Cited by 13
Wnt/β-Catenin Inhibition by CWP232291 as a Novel Therapeutic Strategy in Ovarian Cancer
Wang, W., Cho, U., Yoo, A., Jung, C.-L., Kim, B., Kim, H., Lee, J., Jo, H., Han, Y., Song, M.-H., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.852260 · Cited by 16
Zhang, W., & Zheng, X. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1122322 · Cited by 15
Organoids as an Enabler of Precision Immuno-Oncology
Zhao, J., Fong, A. S. W., Seow, S. V., & Toh, H. C. (2023) · Cells · doi:10.3390/cells12081165 · Cited by 13
Jiang, W., Gu, G., Zhang, Y., Song, Y., Shi, M., Wang, G., Li, H., Tao, T., Qin, J., Li, X., et al. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106942 · Cited by 13
Xu, Y., Zhou, A., Chen, W., Yan, Y., Chen, K., Zhou, X., Tian, Z., Zhang, X., Wu, H., Fu, Z., et al. (2023) · Advanced Materials · doi:10.1002/adma.202304172 · Cited by 13
Zhu, L., Cheng, C., Liu, S., Yang, L., Han, P., Cui, T., & Zhang, Y. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1343177 · Cited by 15
Li, J., Liu, J., Xia, W., Yang, H., Sha, W., & Chen, H. H. (2024) · Technology in Cancer Research & Treatment · doi:10.1177/15330338231221856 · Cited by 13
Future Match Making: When Pediatric Oncology Meets Organoid Technology
Barbet, V., & Broutier, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.674219 · Cited by 19
Recapitulating the Cancer Microenvironment Using Bioprinting Technology for Precision Medicine
Kim, J., Jang, J., & Cho, D. (2021) · Micromachines · doi:10.3390/mi12091122 · Cited by 13
Atypical cyclin P regulates cancer cell stemness through activation of the WNT pathway
Sánchez-Botet, A., Quandt, E., Masip, N., Escribá, R., Novellasdemunt, L., Gasa, L., Li, V. S. W., Raya, Á., Clotet, J., & Ribeiro, M. P. C. (2021) · Cellular Oncology · doi:10.1007/s13402-021-00636-7 · Cited by 13
Vascularization of Patient-Derived Tumoroid from Non-Small-Cell Lung Cancer and Its Microenvironment
Seitlinger, J., Nounsi, A., Idoux‐Gillet, Y., Pujol, E. S., Lê, H., Grandgirard, E., Olland, A., Lindner, V., Zaupa, C., Balloul, J., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10051103 · Cited by 13
Application of colloidal photonic crystals in study of organoids
Huang, K., Li, Q., Xue, Y., Wang, Q., Chen, Z., & Gu, Z. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115075 · Cited by 13
An Organotypic Microcosm for the Pancreatic Tumor Microenvironment
Lin, M., Gao, M., Pandalai, P. K., Cavnar, M. J., & Kim, J. (2020) · Cancers · doi:10.3390/cancers12040811 · Cited by 13
Optimal, Large-Scale Propagation of Mouse Mammary Tumor Organoids
Wrenn, E. D., Moore, B. M., Greenwood, E., McBirney, M., & Cheung, K. J. (2020) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-020-09464-1 · Cited by 14
Elucidation of CRISPR-Cas9 Application in Novel Cellular Immunotherapy.Preprint
Quazi, S. (2021) · Preprints.org · doi:10.20944/preprints202108.0387.v1 · Cited by 12
Organoid Cultures for the Study of Mammary Biology and Breast Cancer: The Promise and ChallengesPreprint
Muthuswamy, S. K., & Brugge, J. S. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041661 · Cited by 13
Role of mTOR through Autophagy in Esophageal Cancer Stemness
Du, L., Wang, D., Nagle, P. W., Groen, A. H., Zhang, H., Muijs, C. T., Plukker, J. T. M., & Coppes, R. P. (2022) · Cancers · doi:10.3390/cancers14071806 · Cited by 12
Canet-Jourdan, C., Pagès, D.-L., Nguyen-Vigouroux, C., Cartry, J., Zajac, O., Desterke, C., Lopez, J.-B., Gutierrez-Mateyron, E., Signolle, N., Adam, J., et al. (2022) · Journal of Cell Science · doi:10.1242/jcs.259256 · Cited by 17
Pan, H., Lee, C.-W., Wu, L., Hsu, H., Tung, Y., Liao, W., & Lee, C. (2023) · APL Bioengineering · doi:10.1063/5.0115464 · Cited by 12
Yang, Z., Yu, J. Q., & Wong, C. C. (2024) · Cells · doi:10.3390/cells13161312 · Cited by 12
Tumor organoids to study gastroesophageal cancer: a primer
Jin, R. U., & Mills, J. C. (2020) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaa035 · Cited by 13
Devall, M. A. M., Dampier, C. H., Eaton, S. D., Ali, M. W., Díez‐Obrero, V., Moratalla-Navarro, F., Bryant, J., Jennelle, L. T., Moreno, V. R., Powell, S. M., et al. (2021) · Oncotarget · doi:10.18632/oncotarget.28058 · Cited by 12
Kujur, P. K., Flores, B. C. T., Ramalingam, N., Chinen, L. T. D., & Jeffrey, S. S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-35805-1_5 · Cited by 12
Ex Vivo Assessment of Tumor-Targeting Fluorescent Tracers for Image-Guided Surgery
Elekonawo, F. M. K., de Gooyer, J. M., Bos, D. L., Goldenberg, D. M., Boerman, O. C., Brosens, L. A. A., Bremers, A. J. A., de Wilt, J. H. W., & Rijpkema, M. (2020) · Cancers · doi:10.3390/cancers12040987 · Cited by 12
Ins-ATP: Deep estimation of ATP for organoid based on high throughput microscope images
Bian, X., Chen, S., & Liu, W. (2025) · Methods · doi:10.1016/j.ymeth.2025.01.012 · Cited by 11
Cancer patient-derived organoids: Novel models for the study of natural products
Liu, S., Zhang, R., Liu, Y., Lin, X., & Chen, J. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.114373 · Cited by 14
Dorrigiv, D., Goyette, P.-A., St‐Georges‐Robillard, A., Mes‐Masson, A., & Gervais, T. (2023) · Cancers · doi:10.3390/cancers15041060 · Cited by 12
Establishment and Culture of Patient-Derived Breast Organoids
Aggarwal, D., Russo, S., Naik, P. K., Bhatia, S., & Spector, D. L. (2023) · Journal of Visualized Experiments · doi:10.3791/64889 · Cited by 15
Avcı, Ç. B., Bağca, B. G., Shademan, B., Takanlou, L. S., Takanlou, M. S., & Nourazarian, A. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1401504 · Cited by 11
Exploring tumor organoids for cancer treatment
Jin, H., Yang, Q., Yang, J., Wang, F., Feng, J., Lei, L., & Dai, M. (2024) · APL Materials · doi:10.1063/5.0216185 · Cited by 11
Compressible Hollow Microlasers in Organoids for High-Throughput and Real-Time Mechanical Screening
Fang, G., Ho, B. X., Xu, H., Gong, C., Qiao, Z., Liao, Y., Zhu, S., Lu, H., Nie, N., Zhou, T., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c08886 · Cited by 12
Masters of adaptation: How cancer and immune cell plasticity mediates tumor progression
Rosenbaum, S. R., Fields, K. M., & Ford, H. L. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003301 · Cited by 12
Organoids: A Platform Ready for Glioblastoma Precision Medicine?
Jin, W., Jin, M., & Tu, Y. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.01.016 · Cited by 11
A Systematically Reduced Mathematical Model for Organoid Expansion
Ellis, M. A., Dalwadi, M. P., Ellis, M. J., Byrne, H. M., & Waters, S. L. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.670186 · Cited by 11
Application of Organoids in Carcinogenesis Modeling and Tumor Vaccination
Wang, Z., Zhao, S., Lin, X., Chen, G., Kang, J., Ma, Z., Wang, Y., Li, Z., Xiao, X., He, A., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.855996 · Cited by 13
Pancreatic cancer derived 3D organoids as a clinical tool to evaluate the treatment response
Shukla, H. D., Đukić, T., Roy, S. K., Bhandary, B., Gerry, A., Poirier, Y. P., Lamichhane, N., Molitoris, J. K., Carrier, F., Banerjee, A., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1072774 · Cited by 11
Zuo, M., Zhang, S., Chen, S., He, Y., Li, J., Xiang, Y., Yuan, Y., Li, T., Yang, W., Wang, Z., et al. (2025) · Oncogene · doi:10.1038/s41388-025-03601-y · Cited by 14
Tumor immune organoids in immunotherapy resistance and drug screening
Zhang, M., Li, L., Pu, H., Yan, W., Zhang, X., Guo, X., Zhao, Y., Meng, Q., & Yin, M. (2026) · Drug Resistance Updates · doi:10.1016/j.drup.2026.101360 · Cited by 11
Wang, J., Sui, Z., Huang, W., Yu, Z., & Guo, L. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.04.035 · Cited by 13
Cutrona, M. B., Wu, J., Yang, K., Peng, J., & Chen, T. (2024) · iScience · doi:10.1016/j.isci.2024.110289 · Cited by 10
Dalvin, L. A., Andrews-Pfannkoch, C. M., Miley, D. R., Hogenson, T. L., Erickson, S. A., Malpotra, S., Anderson, K. J., Omer, M. E., Almada, L. L., Zhang, C., et al. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.13.60 · Cited by 10
Xu, X., Guo, S., Gu, H., Cha, Z., Shi, X., Yin, X., Wang, H., Gao, S., Li, B., Zhu, L., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.181873 · Cited by 11
Kaur, H., Wright, J. A., Worthley, D. L., Murphy, E. M. A., & Woods, S. L. (2025) · Organoids · doi:10.3390/organoids4010002 · Cited by 11
Wang, Y., Zhang, Z., Li, X., Lu, X., ZhuanSun, X.-M., Li, Q., Zhang, J., Xu, X., Liu, X., Yuan, W., et al. (2025) · In vitro models · doi:10.1007/s44164-025-00084-9 · Cited by 11
Engineering organoid microfluidic system for biomedical and health engineering: A review
Xing, Y., Liu, J., Guo, X., Liu, H., Zeng, W., Wang, Y., Zhang, C., Lu, Y., Dong, H., Ma, S., et al. (2020) · Chinese Journal of Chemical Engineering · doi:10.1016/j.cjche.2020.11.013 · Cited by 11
Organoids: approaches and utility in cancer research
Zhou, B., Feng, Z., Xu, J., & Xie, J. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002477 · Cited by 10
Kuo, Y. P., Nombela‐Arrieta, C., & Carja, O. (2024) · Nature Communications · doi:10.1038/s41467-024-48617-2 · Cited by 18
Suri, R., Zimmerman, J. W., & Burkhart, R. A. (2020) · Annals of Pancreatic Cancer · doi:10.21037/apc-20-29 · Cited by 11
Toward improved models of human cancer
Welm, B. E., Vaklavas, C., & Welm, A. L. (2021) · APL Bioengineering · doi:10.1063/5.0030534 · Cited by 10
Metadata
- Authors
- Tuveson, D., & Clevers, H.
- Affiliations
- Cold Spring Harbor Laboratory (US)
- Royal Netherlands Academy of Arts and Sciences (NL)
- Corresponding author
- Tuveson, David
- Clevers, Hans
- Venue
- Science
- Published
- 2019-06-07
- Volume
- 364
- Issue
- 6444
- Pages
- 952-955
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2948402706
- Cited by
- 935
- References
- 53
- Citations by year
- 2026: 111 · 2025: 122 · 2024: 134 · 2023: 156 · 2022: 125 · 2021: 154 · 2020: 116 · 2019: 15
- FWCI
- 42.84
- Type
- journal article
- Language
- en
- Open access
- green
- dspace.library.uu.nl
- Licence
- other-oa
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Funders
- National Cancer Institute (NIH 5P30CA45508-29, 5P50CA101955-07, P20CA192996-03, U01CA210240-01A1, 1R01CA188134-01)
- Lustgarten Foundation (Dedicated Laboratory)
- European Research Council (EU-ERC-670133 Organoid)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- tumor organoids, tumor models, organoid engineering, CRISPR gene editing, tumor microenvironment, cancer immunotherapy, drug response prediction, precision oncology, stem cell-derived organoids, fibroblasts, immune cells
- MeSH terms
- Gene Editing, Humans, Models, Biological, Neoplasms, Organoids, Stem Cells, Biological Specimen Banks, Coculture Techniques, Precision Medicine, Tumor Microenvironment, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
